Literature DB >> 25367030

TRPM7 involvement in cancer: a potential prognostic factor.

Isabelle Dhennin-Duthille1, Mathieu Gautier1, Irina Korichneva1, Halima Ouadid-Ahidouch1.   

Abstract

Calcium (Ca(2+)) and magnesium (Mg(2+)) are important metal elements that regulate a variety of cellular processes such as proliferation, migration, and apoptosis, in cancer cells. Among the ionic channels mediating intracellular entry, the transient receptor potential melastatin type 7 (TRPM7) channel is of particular interest, it being a non-selective, cationic channel mediating both Ca(2+) and Mg(2+) influx. TRPM7 is highly expressed in a number of human cancer tissues and cell lines. In this review, we summarise current knowledge on the physiological role of the dual function TRPM7 chanzyme, the potential application of TRPM7 as a diagnostic and prognostic marker of cancer progression with respect to clinical and pathological characteristics, and the molecular mechanisms implicated in cancerogenesis that specifically involve Ca(2+) and Mg(2+) influx through TRPM7 or kinase activity and interaction with cytoskeletal proteins.

Entities:  

Keywords:  TRPM7; channel activity; kinase function; migration; proliferation

Mesh:

Substances:

Year:  2014        PMID: 25367030     DOI: 10.1684/mrh.2014.0367

Source DB:  PubMed          Journal:  Magnes Res        ISSN: 0953-1424            Impact factor:   1.115


  5 in total

Review 1.  Constitutive calcium entry and cancer: updated views and insights.

Authors:  Olivier Mignen; Bruno Constantin; Marie Potier-Cartereau; Aubin Penna; Mathieu Gautier; Maxime Guéguinou; Yves Renaudineau; Kenji F Shoji; Romain Félix; Elsa Bayet; Paul Buscaglia; Marjolaine Debant; Aurélie Chantôme; Christophe Vandier
Journal:  Eur Biophys J       Date:  2017-05-17       Impact factor: 1.733

2.  Hypomagnesemia and Its Relationship with Oxidative Stress Markers in Women with Breast Cancer.

Authors:  Daila Leite Chaves Bezerra; Priscyla Maria Vieira Mendes; Stéfany Rodrigues de Sousa Melo; Loanne Rocha Dos Santos; Raisa de Oliveira Santos; Sabas Carlos Vieira; Gilberto Simeone Henriques; Betania de Jesus E Silva de Almendra Freitas; Dilina do Nascimento Marreiro
Journal:  Biol Trace Elem Res       Date:  2021-01-14       Impact factor: 3.738

3.  Knockdown of TRPM7 prevents tumor growth, migration, and invasion through the Src, Akt, and JNK pathway in bladder cancer.

Authors:  Eun Hye Lee; So Young Chun; Bomi Kim; Bo Hyun Yoon; Jun Nyung Lee; Bum Soo Kim; Eun Sang Yoo; Sangkyu Lee; Phil Hyun Song; Tae Gyun Kwon; Yun-Sok Ha
Journal:  BMC Urol       Date:  2020-09-09       Impact factor: 2.264

4.  Promoter methylation of transient receptor potential melastatin-related 7 (TRPM7) predicts a better prognosis in patients with Luminal A breast cancers.

Authors:  Yuanyuan Wang; Rong Lu; Pu Chen; Rongrong Cui; Meiju Ji; Xiaozhi Zhang; Peng Hou; Yiping Qu
Journal:  BMC Cancer       Date:  2022-09-05       Impact factor: 4.638

5.  Expression and prognostic value of TRPM7 in canine mammary tumours.

Authors:  Seulji Lee; Sungin Lee; Wan Hee Kim
Journal:  Vet Comp Oncol       Date:  2021-05-04       Impact factor: 2.613

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.